However, not all glucose-lowering and risk-factor management trials have shown a positive effect on CV events over the relatively short timeframe of CVOTs and therefore, risk-factor modification alone cannot explain the magnitude of the benefits observed ( Figure 3 ) ( Figure 3 In atherogenesis, low-density lipoprotein (LDL) cholesterol is transported into the intima layer of arterial blood vessels where reactive oxygen species (ROS) can lead to the formation of oxidized LDL (oxLDL) particles
Researchers have known this for decades
obesity trial: cardiometabolic markers, liver fat reduction, lipid profiles Hepatology (2024) Triple agonists in NAFLD/NASH: hepatic steatosis resolution (preclinical and clinical evidence) The Lancet (2023) Supplementary Data Rosenstock et al
He says, "I was ready, and I was behind it
Aim for at least half your body weight in ounces of water per day, more if you are exercising or experiencing GI symptoms
UK clinical practice follows the precautions outlined in the Summary of Product Characteristics (SmPC) for each medication